drugset / Trial / NCT03156127

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

NCT03156127

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the Pharmacokinetics and Safety / Tolerability of BR-UPS (Ulipristal acetate) 5 mg tablet with Inisia (Ulipristal acetate) 5 mg tablet in healthy female volunteers

Timeline

Start
2017-05-19
Primary completion
2017-07
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulipristal Acetate Unknown 5 mg Oral

Indications